NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Capra Biosciences

Capra Biosciences

Private
Sterling, VirginiaHealthcare & Life Scienceshttps://www.caprabiosciences.com/

Last Round

Grant

Jul 19, 2024

Total Funding Raised

$10.45M

Company Overview

Capra Biosciences is a biotechnology company that develops a proprietary bioreactor platform to produce sustainable, bio-based chemicals as alternatives to petrochemicals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

biomanufacturingmicrobial fermentationsynbiobioreactor technologyspecialty chemicalsbio-based ingredientssustainable manufacturingactive pharmaceutical ingredientAPIfeedstock flexibilitybiofilmstrain engineeringbioprocess modelingclean techcontract manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Capra Biosciences Comparables

Compare Capra Biosciences with similar companies based on industry and business-model similarity.

Capra Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZymoChem
81%
TripleW
78%
Manus Bio
73%

Capra Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 19, 2024
SeedApr 29, 2024
SeedDec 12, 2023
GrantApr 24, 2023
Pre SeedJun 6, 2022
Accelerator
Mar 17, 2021

Key People

Founding team and executive leadership

Elizabeth Onderko

Chief Executive Officer

Executive Team

Capra Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 9, 2025

    Partnering with ATCC, Virginia Tech, and Syracuse University on feedstock switching.

  • Jul 19, 2024

    $8M grant from U.S. Department of Health and Human Services

Capra Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Capra Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Capra Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSterling, Virginia
Employee Range25
Year Founded2020
Last FundingJul 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.